Xilio Therapeutics (XLO) Debt Ratio (2020 - 2023)

Xilio Therapeutics has disclosed Debt Ratio across 4 years of filings, most recently posting 0.05 for Q4 2023.

• In Q4 2023, Debt Ratio fell 22.99% year-over-year to 0.05; the TTM figure through Dec 2023 stood at 0.05 (down 22.99% YoY), while the FY2023 annual figure was 0.05, down 22.99% from the prior year.
• Debt Ratio came in at 0.05 for Q4 2023 at Xilio Therapeutics, down from 0.06 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.27 in Q4 2020 to a low of 0.04 in Q4 2021.
• Average Debt Ratio over 4 years is 0.08, with a median of 0.06 recorded in 2023.
• Year-over-year, Debt Ratio sank 83.55% in 2021 and surged 60.01% in 2022.
• Over 4 years, Debt Ratio stood at 0.27 in 2020, then slumped by 83.55% to 0.04 in 2021, then soared by 60.01% to 0.07 in 2022, then retreated by 22.99% to 0.05 in 2023.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.05 in Q4 2023, 0.06 in Q3 2023, and 0.08 in Q2 2023.